Subscribe free

HPB & Spleen ·

Surgeons See 10-Year Survival in Resection of Liver Metastases

Resection of solitary colorectal liver metastases leads to excellent long-term survival, but outcomes depend on lymph node status and tumor size.

  • Median overall survival is 10 years; 52% remain recurrence-free at 3 years.
  • Salvage therapy for 51% of recurrences boosts overall survival significantly (5.89 years vs. 2.24 years; p<0.001).
  • Patients with more than three positive lymph nodes face worse outcomes (HR 2.19).

Adjuvant hepatic artery infusion chemotherapy enhances survival and decreases liver recurrence.

Journal Article by Liu M, Seier K (…) D’Angelica M et 7 al. in Ann Surg Oncol

© 2026. Society of Surgical Oncology.

read the whole article in Ann Surg Oncol

open it in PubMed

Summaries are written to help you decide what to read. They do not replace the full paper.

Free · 5 minutes a day

Get every new paper in HPB & Spleen.

Plus the Daily Selection: the five most relevant papers of the day, each cut to its key points.

Specialty newsletters: every new paper in your field, as a list of titles linked to the source. Daily Selection: the five that matter, cut to their key points.

FreeNo spamOne-click unsubscribe

More in HPB & Spleen

The latest stitches

All papers in HPB & Spleen →